Glaukos Corporation
GKOS
Ранг среди акций
#2023
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Цена акции
$174.03
Рыночная капитализация
$10.26B
Изменение (1 день)
4.34%
Изменение (1 год)
118.99%
Страна
US
Торговля Glaukos Corporation (GKOS)
Категория
Healthcare
История дроблений акций Glaukos Corporation (GKOS)
Акции Glaukos Corporation (символ: GKOS) прошли через 0 дроблений.
Последнее дробление произошло Oct 20, 2026.
Одна акция GKOS, купленная до Oct 20, 2026, сейчас соответствует 0 акциям GKOS.
Последнее дробление произошло Oct 20, 2026.
Одна акция GKOS, купленная до Oct 20, 2026, сейчас соответствует 0 акциям GKOS.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
